These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20438364)
41. The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Gürdöl F; Işbilen E; Yilmaz H; Isbir T; Dirican A Clin Chim Acta; 2004 Mar; 341(1-2):127-31. PubMed ID: 14967168 [TBL] [Abstract][Full Text] [Related]
42. The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis. Köppel H; Renner W; Gugl A; Cichocki L; Gasser R; Wascher TC; Pilger E Thromb Haemost; 2004 Jan; 91(1):76-9. PubMed ID: 14691571 [TBL] [Abstract][Full Text] [Related]
43. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease. Al-Fakhri N; Linhart RE; Philipp M; Heidt M; Hehrlein FW; Gardemann A; Katz N J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792 [TBL] [Abstract][Full Text] [Related]
44. Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation. Ueberham L; Bollmann A; Shoemaker MB; Arya A; Adams V; Hindricks G; Husser D Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):732-7. PubMed ID: 23876437 [TBL] [Abstract][Full Text] [Related]
45. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Freitas-Silva M; Pereira D; Coelho C; Bicho M; Lopes C; Medeiros R Cancer Genet Cytogenet; 2004 Nov; 155(1):42-6. PubMed ID: 15527901 [TBL] [Abstract][Full Text] [Related]
46. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Srivastava A; Pandey SN; Choudhuri G; Mittal B Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329 [TBL] [Abstract][Full Text] [Related]
48. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men. Baghai TC; Schule C; Zill P; Deiml T; Eser D; Zwanzger P; Ella R; Rupprecht R; Bondy B Neurosci Lett; 2004 Jun; 363(1):38-42. PubMed ID: 15157992 [TBL] [Abstract][Full Text] [Related]
49. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Sugimoto M; Furuta T; Shirai N; Ikuma M; Sugimura H; Hishida A Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1929-34. PubMed ID: 17035401 [TBL] [Abstract][Full Text] [Related]
50. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Al-Awadhi AM; Hasan EA; Sharma PN; Haider MZ; Al-Saeid K Rheumatol Int; 2007 Oct; 27(12):1119-23. PubMed ID: 17440728 [TBL] [Abstract][Full Text] [Related]
51. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC. Oruç N; Lamb J; Whitcomb DJ; Sass DA Turk J Gastroenterol; 2008 Dec; 19(4):250-3. PubMed ID: 19119484 [TBL] [Abstract][Full Text] [Related]
52. Relationship between the angiotensin I-converting enzyme insertion/deletion (I/D) polymorphism and cardiovascular risk factors in healthy young Mexican women. Vallejo M; Martínez-Palomino G; Ines-Real S; Pérez-Hernández N; Juárez-Rojas JG; Vargas-Alarcón G Genet Test Mol Biomarkers; 2009 Apr; 13(2):237-42. PubMed ID: 19371224 [TBL] [Abstract][Full Text] [Related]
53. The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis. Patwardhan M; Pradhan V; Taylor LH; Thakkar V; Kharkar V; Khopkar U; Ghosh K; Gawkrodger DJ; Teare MD; Weetman AP; Kemp EH Br J Dermatol; 2013 Jun; 168(6):1195-204. PubMed ID: 23278772 [TBL] [Abstract][Full Text] [Related]
54. The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis. Nadalin S; Buretić-Tomljanović A; Lavtar P; Starčević Čizmarević N; Hodžić A; Sepčić J; Kapović M; Peterlin B; Ristić S Brain Behav; 2017 Jan; 7(1):e00600. PubMed ID: 28127518 [TBL] [Abstract][Full Text] [Related]
55. Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy. Lee JM; Lo AC; Yang SY; Tsau HS; Chen RJ; Lee YC Ann Surg; 2005 Apr; 241(4):659-65. PubMed ID: 15798469 [TBL] [Abstract][Full Text] [Related]
56. Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. González Ordóñez AJ; Fernández Carreira JM; Medina Rodríguez JM; Martín Sánchez L; Alvarez Díaz R; Alvarez Martinez MV; Coto Garcia E Blood Coagul Fibrinolysis; 2000 Jul; 11(5):485-90. PubMed ID: 10937809 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis. Li YF; Zhu XM; Liu F; Xiao CS; Bian YF; Li H; Cai J; Li RS; Yang XC PLoS One; 2012; 7(6):e37396. PubMed ID: 22723835 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS. Cruces P; Díaz F; Puga A; Erranz B; Donoso A; Carvajal C; Wilhelm J; Repetto GM Intensive Care Med; 2012 Jan; 38(1):113-9. PubMed ID: 22005825 [TBL] [Abstract][Full Text] [Related]
59. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Srivastava A; Pandey SN; Choudhuri G; Mittal B Mol Genet Metab; 2008 May; 94(1):83-9. PubMed ID: 18178499 [TBL] [Abstract][Full Text] [Related]
60. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease. Renner W; Pabst E; Paulweber B; Malaimare L; Iglseder B; Wascher TC; Pilger E Atherosclerosis; 2002 Nov; 165(1):175-8. PubMed ID: 12208484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]